What is Incyte Corporation share price today?

Incyte Corporation (INCY) share price today is {{live_price}}.

Can Indians buy Incyte Corporation shares?

Yes, Indians can invest in the Incyte Corporation (INCY) from India. With INDmoney, you can buy Incyte Corporation at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Incyte Corporation at zero transaction cost.

How can I buy Incyte Corporation shares from India?

It is very easy to buy Incyte Corporation from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Incyte Corporation be purchased?

Yes, you can buy fractional shares of Incyte Corporation with INDmoney app.

What are the documents required to start investing in Incyte Corporation stocks?

To start investing in Incyte Corporation, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Incyte Corporation

Today’s highest price of Incyte Corporation (INCY) is {{1_rba_end}}. Today’s lowest price of Incyte Corporation (INCY) is {{1_rba_st}}.

What is today's market capitalisation of Incyte Corporation

Today's market capitalisation of Incyte Corporation INCY is 14.0B

What is the 52 Week High and Low Range of Incyte Corporation

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Incyte Corporation is down from its 52 Week High?

Incyte Corporation (INCY) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Incyte Corporation is up from its 52 Week low?

Incyte Corporation (INCY) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Incyte Corporation?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Incyte Corporation

Mr. Herve Hoppenot is the current Chief Executive Officer (CEO) of Incyte Corporation.

Incyte Corporation Share Price: INCY (Incyte Corporation) Stock Price Today & Updates

Performance

$62.34
$62.88
$62.58
0.38%
Downside
Day's Volatility :0.86%
Upside
0.48%
$62.32
$86.29
$62.58
0.42%
Downside
52 Weeks Volatility :27.78%
Upside
27.48%

Returns

Period	Incyte Corporation
3 Months	-18.23%
6 Months	-19.51%
1 Year	-17.45%
3 Years	-37.7%

Highlights

Market Capitalization	14.0B
Book Value	$20.01
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	1.43
PE Ratio	43.97
PEG Ratio	0.47
Wall Street Target Price	82.24

Profit Margin	9.35%
Operating Margin TTM	14.47%

Return On Assets TTM	5.78%
Return On Equity TTM	7.79%

Revenue TTM	3.5B
Revenue Per Share TTM	15.6
Quarterly Revenue Growth YOY	10.299999999999999%
Gross Profit TTM	1.6B
EBITDA	575.7M
Diluted Eps TTM	1.43
Quarterly Earnings Growth YOY	-0.43

EPS Estimate Current Year	3.4
EPS Estimate Next Year	4.69
EPS Estimate Current Quarter	0.75
EPS Estimate Next Quarter	0.91

Analyst Recommendation

Buy

55%Buy

44%Hold

0

0%Sell

Based on 27 Wall street analysts offering stock ratings for Incyte Corporation(by analysts ranked 0 to 5 stars)

Based on 27 analyst

Current
1M Ago
3M Ago

Buy

15

16

Hold

12

11

10

Sell

00

1

Analyst Forecast

What analysts predicted

Upside of 31.42%

Current $62.58

Target $82.24

Company Financials

	FY17	Y/Y Change
Revenue	1.5B	↑ 38.93%
Net Income	-313.1M	↓ 400.46%
Net Profit Margin	-20.38%	↓ 29.81%

	FY18	Y/Y Change
Revenue	1.9B	↑ 22.5%
Net Income	109.5M	↓ 134.97%
Net Profit Margin	5.82%	↑ 26.2%

	FY19	Y/Y Change
Revenue	2.2B	↑ 14.71%
Net Income	446.9M	↑ 308.16%
Net Profit Margin	20.7%	↑ 14.88%

	FY20	Y/Y Change
Revenue	2.7B	↑ 23.53%
Net Income	-295.7M	↓ 166.17%
Net Profit Margin	-11.09%	↓ 31.79%

	FY21	Y/Y Change
Revenue	3.0B	↑ 11.98%
Net Income	948.6M	↓ 420.79%
Net Profit Margin	31.76%	↑ 42.85%

	FY22	Y/Y Change
Revenue	3.4B	↑ 13.67%
Net Income	340.7M	↓ 64.09%
Net Profit Margin	10.04%	↓ 21.72%

	Q4 FY21	Q/Q Change
Revenue	862.9M	↑ 6.13%
Net Income	563.9M	↑ 210.25%
Net Profit Margin	65.35%	↑ 43.0%

	Q1 FY22	Q/Q Change
Revenue	733.2M	↓ 15.02%
Net Income	38.0M	↓ 93.26%
Net Profit Margin	5.18%	↓ 60.17%

	Q2 FY22	Q/Q Change
Revenue	911.4M	↑ 24.3%
Net Income	161.4M	↑ 324.91%
Net Profit Margin	17.71%	↑ 12.53%

	Q3 FY22	Q/Q Change
Revenue	823.3M	↓ 9.67%
Net Income	112.8M	↓ 30.14%
Net Profit Margin	13.7%	↓ 4.01%

	Q4 FY22	Q/Q Change
Revenue	926.7M	↑ 12.56%
Net Income	28.5M	↓ 74.76%
Net Profit Margin	3.07%	↓ 10.63%

	Q1 FY23	Q/Q Change
Revenue	17.9M	↓ 98.07%
Net Income	1000.0K	↓ 96.49%
Net Profit Margin	5.59%	↑ 2.52%

	FY17	Y/Y Change
Total Assets	2.3B	↑ 40.52%
Total Liabilities	672.0M	↓ 44.88%

	FY18	Y/Y Change
Total Assets	2.6B	↑ 14.9%
Total Liabilities	719.8M	↑ 7.12%

	FY19	Y/Y Change
Total Assets	3.4B	↑ 29.52%
Total Liabilities	828.3M	↑ 15.08%

	FY20	Y/Y Change
Total Assets	3.6B	↑ 3.92%
Total Liabilities	949.7M	↑ 14.64%

	FY21	Y/Y Change
Total Assets	4.9B	↑ 38.54%
Total Liabilities	1.2B	↑ 22.5%

	FY22	Y/Y Change
Total Assets	5.8B	↑ 18.4%
Total Liabilities	1.5B	↑ 26.43%

	Q4 FY21	Q/Q Change
Total Assets	4.9B	↑ 17.49%
Total Liabilities	1.2B	↑ 10.78%

	Q1 FY22	Q/Q Change
Total Assets	5.1B	↑ 2.45%
Total Liabilities	1.2B	↑ 2.39%

	Q2 FY22	Q/Q Change
Total Assets	5.3B	↑ 5.24%
Total Liabilities	1.2B	↑ 3.6%

	Q3 FY22	Q/Q Change
Total Assets	5.5B	↑ 3.59%
Total Liabilities	1.3B	↑ 4.02%

	Q4 FY22	Q/Q Change
Total Assets	5.8B	↑ 6.0%
Total Liabilities	1.5B	↑ 14.59%

	Q1 FY23	Q/Q Change
Total Assets	79.6M	↓ 98.64%
Total Liabilities	33.3M	↓ 97.74%

	FY17	Y/Y Change
Operating Cash Flow	-93.0M	↓ 130.51%
Investing Cash Flow	-350.0M	↑ 50.54%
Financing Cash Flow	690.2M	↑ 1076.86%

	FY18	Y/Y Change
Operating Cash Flow	336.2M	↓ 461.58%
Investing Cash Flow	-86.4M	↓ 75.31%
Financing Cash Flow	14.7M	↓ 97.88%

	FY19	Y/Y Change
Operating Cash Flow	710.7M	↑ 111.36%
Investing Cash Flow	-87.5M	↑ 1.19%
Financing Cash Flow	45.7M	↑ 211.87%

	FY20	Y/Y Change
Operating Cash Flow	-124.6M	↓ 117.53%
Investing Cash Flow	-269.0M	↑ 207.59%
Financing Cash Flow	71.7M	↑ 56.87%

	FY21	Y/Y Change
Operating Cash Flow	749.5M	↓ 701.52%
Investing Cash Flow	-207.7M	↓ 22.79%
Financing Cash Flow	6.2M	↓ 91.39%

	FY22	Y/Y Change
Operating Cash Flow	969.9M	↑ 29.41%
Investing Cash Flow	-78.5M	↓ 62.18%
Financing Cash Flow	-794.0K	↓ 112.86%

	Q4 FY21	Q/Q Change
Operating Cash Flow	115.4M	↓ 54.78%
Investing Cash Flow	-66.0M	↑ 101.65%
Financing Cash Flow	9.0M	↓ 146.55%

	Q1 FY22	Q/Q Change
Operating Cash Flow	215.7M	↑ 87.03%
Investing Cash Flow	-16.7M	↓ 74.64%
Financing Cash Flow	96.0K	↓ 98.93%

	Q2 FY22	Q/Q Change
Operating Cash Flow	174.2M	↓ 19.27%
Investing Cash Flow	-12.5M	↓ 25.48%
Financing Cash Flow	15.9M	↑ 16463.54%

	Q3 FY22	Q/Q Change
Operating Cash Flow	296.4M	↑ 70.18%
Investing Cash Flow	-28.4M	↑ 127.58%
Financing Cash Flow	-14.3M	↓ 190.0%

	Q4 FY22	Q/Q Change
Operating Cash Flow	283.7M	↓ 4.29%
Investing Cash Flow	-20.9M	↓ 26.37%
Financing Cash Flow	-2.5M	↓ 82.67%

Technicals Summary

Sell

Neutral

Buy

Incyte Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin

Institutional Holdings

Baker Bros Advisors LP
16.22%
Vanguard Group Inc
9.75%
BlackRock Inc
8.89%
Dodge & Cox
8.67%
Royal Bank of Canada
4.23%
State Street Corporation
4.18%

Organization	Incyte Corporation
Employees	2324
CEO	Mr. Herve Hoppenot
Industry	Health Technology

Incyte Corporation (INCY)